Bezmialem Vakif University, Medical Faculty, Department of Medical Oncology, Istanbul, Turkey.
Yozgat City Hospital, Department of Hematology, Yozgat, Turkey.
J Cancer Res Ther. 2022 Apr-Jun;18(3):846-848. doi: 10.4103/jcrt.JCRT_1008_20.
Breast cancer is the most common cancer in women and 2-11% of the cases are bilateral. Bilateral breast cancer frequently emerges as a second primary cancer. Lymphoma and mucinous carcinoma of breast are very rare. Here we present a case, of bilateral breast cancer with metachronous lymphoma and mucinous carcinoma.
57-year old female had received chemotherapy and radiotherapy for stage IA Diffuse Large B Cell Lymphoma (DLBCL) located in right breast. At 14th month of her breast DLBCL diagnosis, a diagnosis of mucinous carcinoma was determined in her left breast. After surgery, adjuvant anastrozole was initiated. The patient is still in follow-up with remission at her sixth year of DLBCL diagnosis and fifth year of mucinous carcinoma diagnosis.
The evaluation of unilateral breast cancer patients in terms of bilateral breast cancer occurrence risk has become important.
乳腺癌是女性最常见的癌症,2-11%的病例为双侧。双侧乳腺癌常作为第二原发癌出现。乳腺淋巴瘤和黏液癌非常罕见。在此,我们报告一例双侧乳腺癌伴异时性淋巴瘤和黏液癌。
57 岁女性因右侧乳腺弥漫性大 B 细胞淋巴瘤(DLBCL)接受化疗和放疗。在她被诊断为右侧乳腺 DLBCL 后 14 个月,左侧乳腺被诊断为黏液癌。手术后,开始辅助使用阿那曲唑。患者在 DLBCL 诊断的第六年和黏液癌诊断的第五年仍处于缓解期。
对单侧乳腺癌患者进行双侧乳腺癌发生风险评估变得很重要。